is tirzepatide or semaglutide better vs Tirzepatide: Key Differences A lot of our patients
Description
A 2021 study published in the New England Journal of Medicine compared tirzepatide directly to semaglutide in patients with type 2 diabetes
GLP-1 agonists and dipeptidyl-peptidase IV inhibitors, in Diabetes-perspectives in drug therapy , 5374
Please note that this program is NOT suitable for: Individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC)
This also applies to those with endocrine neoplasia syndrome type 2 (MEN 2)
What happens if I stop treatment
